Randomized phase III study of TS-1 [S-1] alone versus TS-1 plus lentinan(LNT) in advanced or recurrent gastric cancer (ACG)
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Lentinan (Primary) ; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Therapeutic Use
- 12 Sep 2017 Results of a subgroup analysis assessing safety and efficacy of S-1 treatment in elderly versus younger patients with advanced or recurrent gastric cancer, presented at the 42nd European Society for Medical Oncology Congress.
- 16 Jan 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 22 Jan 2007 New trial record.